ReviewPharmacological reports : PR2026
The Wistar-Kyoto rat as a model relevant to inattentive ADHD: substrain variability and affective comorbidity.
Review in Pharmacological reports : PR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Wistar-Kyoto (WKY) rats, originally used as a control group for spontaneously hypertensive rats, are increasingly recognized as a valuable model for studying selected neuropsychiatric disorders. This strain exhibits behavioral and neurobiological traits relevant to both depression and inattentive attention-deficit/hyperactivity disorder (ADHD), including behavioral inhibition, increased stress sensitivity, anhedonic behaviors, and deficits in sustained attention. At the same time, a significant challenge remains in the form of considerable variability among WKY substrains, resulting from genetic differences and the breeding practices employed by individual suppliers. This variability may limit the reproducibility of results, but it also holds research value, enabling the analysis of distinct dimensions of mental disorders within related animal models. The aim of this review is to integrate available data on the genealogy, genetic variability, and behavioral phenotypes of WKY rats, with particular emphasis on their relevance to ADHD research and on depression-related traits that may influence the interpretation of WKY rats as a reference or disease-relevant strain. The added value of the present review is therefore to provide an integrated ADHD-oriented perspective on the WKY strain, while also considering depression-related and treatment-response traits as biologically relevant components of its complex behavioral phenotype.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.